Geoffrey Rosevear
Family · Johnson City, NYNPI 1225364854
Payments from drug & device makers
Across 232 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$819
- Johnson & Johnson$618
- Pfizer$517
- Amgen$436
- Merck$384
- E.r. Squibb & Sons, L.L.C.$291
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,546100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 53 | $819 |
| Johnson & Johnson | 32 | $618 |
| Pfizer | 34 | $517 |
| Amgen | 21 | $436 |
| Merck | 18 | $384 |
| E.r. Squibb & Sons, L.L.C. | 10 | $291 |
| Boehringer Ingelheim | 10 | $237 |
| AstraZeneca(2 entities) | 13 | $185 |
| Abiomed | 4 | $137 |
| Chiesi USA, Inc. | 5 | $127 |
| Amarin Pharma, Inc. | 4 | $90 |
| GSK | 1 | $85 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $66 |
| Boston Scientific | 2 | $61 |
| Inari Medical, Inc. | 2 | $57 |
| Novo Nordisk | 3 | $55 |
| Medicomp Inc | 1 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $43 |
| Lexicon Pharmaceuticals, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Philips North America LLC | 1 | $32 |
| Teleflex LLC | 1 | $30 |
| Acadia Pharmaceuticals Inc | 1 | $26 |
| UCB, Inc. | 1 | $25 |
| Haemonetics Corporation | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Shockwave Medical, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$126
How this compares
$4,560 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 193 | $261,845 |
| EntrestoSacubitril/Valsartan | 135 | $208,108 |
| FarxigaDapagliflozin Propanediol | 102 | $90,517 |
| XareltoRivaroxaban | 64 | $80,142 |
| TrulicityDulaglutide | 49 | $41,723 |
| JardianceEmpagliflozin | 31 | $38,644 |
| BrilintaTicagrelor | 41 | $33,215 |
| Repatha SureclickEvolocumab | 19 | $17,982 |
| Lacosamide | 25 | $9,329 |
| Metoprolol Succinate | 379 | $8,447 |
| MyrbetriqMirabegron | 34 | $7,837 |
| Incruse ElliptaUmeclidinium Bromide | 18 | $6,797 |
| Asenapine Maleate | 13 | $6,404 |
| Atorvastatin Calcium | 359 | $4,707 |
| Ranolazine ErRanolazine | 38 | $4,539 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $517 | $261,845193 claims |
| NovartisEntresto | $819 | $208,108135 claims |
| AstraZenecaFarxiga, Brilinta | $185 | $123,732143 claims |
| Johnson & JohnsonXarelto | $618 | $80,14264 claims |
| Boehringer IngelheimJardiance | $237 | $38,64431 claims |
| GSKIncruse Ellipta | $85 | $6,79718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,883 family providers in New York.
Other family in Johnson City
- Kara SpalikJohnson City$18K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.